Protalix BioTherapeutics PLX
NYSE PLX
$2.57 -0.07 (-2.65%)
As of: Oct 21, 2026 · 3:59 PM EDT

Protalix BioTherapeutics (PLX) Total Non-Current Liabilities (2010 - 2026)

Updated

Protalix BioTherapeutics (PLX) reported Total Non-Current Liabilities of $7.54 million for Q2 2026, up 67.9% from $4.49 million a year earlier but down 2.3% from the prior quarter.

Analysis

Protalix BioTherapeutics (PLX) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends

At the end of FY2025, Protalix BioTherapeutics posted Total Non-Current Liabilities of $7.6 million, up 65.7% from FY2024.

  • Total Non-Current Liabilities has a five-year compound annual growth rate of -2.2% (FY2020 to FY2025).
  • By year, Total Non-Current Liabilities came in at $4.59 million in FY2024 (-14.1%), $5.34 million in FY2023 (-84.3%), $34 million in FY2022 (-26.9%) and $46.53 million in FY2021 (+447.5%).
  • Five-year quarterly Total Non-Current Liabilities spans a low of $4.36 million in Q1 2025 and a high of $46.53 million in Q4 2021.
  • Year over year, Total Non-Current Liabilities has now increased in each of the last four quarters, with growth averaging 25.5% over the last eight quarters.
  • The high point for year-over-year Total Non-Current Liabilities in five years was Q4 2021 (growth of 447.5%); the low point was Q1 2024 (a decline of 84.7%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $7.72 million (Q1 2026), $7.6 million (Q4 2025) and $7.41 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 60.66 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 105.50 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 106.45 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 80.25 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 48.34 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 33.91 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 78.66 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 35.10 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 97.04 Bn
10 Protalix BioTherapeutics 207.16 Mn 55.78 Mn 12.13 Mn 7.54 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.54 Mn
Mar 31, 2026 7.72 Mn
Dec 31, 2025 7.60 Mn
Sep 30, 2025 7.41 Mn
Jun 30, 2025 4.49 Mn
Mar 31, 2025 4.36 Mn
Dec 31, 2024 4.59 Mn
Sep 30, 2024 4.91 Mn
Jun 30, 2024 4.99 Mn
Mar 31, 2024 5.21 Mn
Dec 31, 2023 5.34 Mn
Sep 30, 2023 5.96 Mn
Jun 30, 2023 26.31 Mn
Mar 31, 2023 34.04 Mn
Dec 31, 2022 34.00 Mn
Sep 30, 2022 33.92 Mn
Jun 30, 2022 39.57 Mn
Mar 31, 2022 40.55 Mn
Dec 31, 2021 46.53 Mn
Sep 30, 2021 40.51 Mn
API Access

Protalix BioTherapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=PLX&period=max&api_key=YOUR_API_KEY